Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study
美国婴儿呼吸道合胞病毒下呼吸道疾病中,Nirsevimab 和 Clesrovimab 的成本效益分析:一项建模研究
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-026-01311-w
Yarnoff, Benjamin; Beuvelet, Matthieu; Soudani, Samira; Neary, Maureen P; Hodges, Erin N; Chit, Ayman; Tribaldos, Maribel; Gabriel, Veronica; Musci, Robert; Geurtsen, Jeroen; Krilov, Leonard R